TY - JOUR
BT - Circulation
PY - 2019
SP - 1463 
EP -  1476
T2 - Circulation
TI - Dapagliflozin effects on biomarkers, symptoms, and functional status in patients with heart failure with reduced ejection fraction
VL - 140
ER -